Pages that link to "Q42258668"
Jump to navigation
Jump to search
The following pages link to Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage (Q42258668):
Displaying 50 items.
- Emergency department treatment of alcohol withdrawal seizures with phenytoin (Q30450419) (← links)
- New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol (Q30463911) (← links)
- Incidence of intravenous site reactions in neurotrauma patients receiving valproate or phenytoin (Q31397048) (← links)
- Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs (Q33956733) (← links)
- No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: "the cure may be worse than the disease"). (Q34147041) (← links)
- Protein binding and CSF penetration of phenytoin following acute oral dosing in man. (Q34622211) (← links)
- Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures (Q35029493) (← links)
- Life-threatening bradyarrhythmia with oral phenytoin overdose (Q35979840) (← links)
- Purple Glove Syndrome after Phenytoin or Fosphenytoin Administration: Review of Reported Cases and Recommendations for Prevention (Q36362730) (← links)
- Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers (Q36876001) (← links)
- A comparative assessment the efficacy of intravenous infusion of sodium valproate and phenytion in the treatment of status epilepticus (Q36917736) (← links)
- Status epilepticus. Clinical features, pathophysiology, and treatment (Q37041705) (← links)
- Phenytoin induced sinoatrial bradyarrhythmia in the perioperative period (Q37443966) (← links)
- Arrhythmia, heart rate variability, and antiepileptic drugs (Q37631681) (← links)
- Requirement for cardiac telemetry during intravenous phenytoin infusion: guideline fact or guideline fiction? (Q38040546) (← links)
- Cardiovascular adverse effects of phenytoin (Q38662067) (← links)
- Clinical features and management of poisoning due to phenytoin (Q38682717) (← links)
- Predictors of Outcome in Children with Status Epilepticus during Resuscitation in Pediatric Emergency Department: A Retrospective Observational Study (Q38725178) (← links)
- Incidence and risk factors of hypotension after intravenous fosphenytoin administration (Q38821508) (← links)
- An Unusual Case of Asystole following Penetrating Neck Trauma and Anoxic Brain Injury. (Q39174315) (← links)
- Antiepileptic drug toxicity: definition and mechanism of action (Q39502944) (← links)
- Seizure management at Auckland City Hospital Emergency Department between July and December 2009: time for a change? (Q39625343) (← links)
- Developments in anticonvulsants (Q40465190) (← links)
- Refractory status epilepticus in adults (Q40826234) (← links)
- Dr watson responds (Q41196768) (← links)
- New drug therapy for acute seizure management (Q41428291) (← links)
- Oral phenytoin toxicity causing sinus arrest: a case report (Q42207400) (← links)
- Cardiopulmonary arrest following intravenous phenytoin loading (Q42214011) (← links)
- Complete atrioventricular block with ventricular asystole following infusion of intravenous phenytoin (Q42277065) (← links)
- Venous irritation related to intravenous administration of phenytoin versus fosphenytoin (Q42285378) (← links)
- Pediatric use of intravenous and intramuscular phenytoin: lessons learned (Q42538655) (← links)
- Association of intravenous phenytoin toxicity with demographic, clinical, and dosing parameters (Q42554581) (← links)
- Aplastic anaemia induced by intravenous phenytoin and lidocaine administration (Q42625591) (← links)
- Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study (Q43712982) (← links)
- Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver disease: role of alkaline phosphatase. (Q43749227) (← links)
- Severe oral phenytoin overdose does not cause cardiovascular morbidity (Q43923900) (← links)
- A comparison of central brain (cerebrospinal and extracellular fluids) and peripheral blood kinetics of phenytoin after intravenous phenytoin and fosphenytoin (Q44547041) (← links)
- Adverse events associated with intravenous phenytoin in children: a prospective study (Q44547044) (← links)
- Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures (Q46180585) (← links)
- Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus (Q46654339) (← links)
- Epileptic seizure disorders. Developments in diagnosis and therapy (Q48552371) (← links)
- Soft tissue injury associated with intravenous phenytoin in a neonate (Q50768227) (← links)
- Phenytoin administration by constant intravenous infusion: selective rates of administration (Q68201164) (← links)
- Intravenous phenytoin loading in patients after neurosurgery and in status epilepticus. A population pharmacokinetic study (Q68324052) (← links)
- IV administration of phenytoin (Q68588679) (← links)
- Single-dose oral phenytoin loading (Q69775573) (← links)
- Emergency phenytoin loading by constant intravenous infusion (Q70386554) (← links)
- Adverse Effects with Administration of Phenytoin: Infusion Pump vs Manual Infusion (Q71801989) (← links)
- Potential underreporting of intravenous phenytoin adverse events (Q78106902) (← links)
- Antiepileptic Drugs: The Old and the New (Q82612830) (← links)